Glucose-responsive and octreotide-sensitive insulinoma

Internal Medicine

Volumn 45, Issue 8, 2006, Pages 519-524

  Izumiyama, Hajime ^a   Gotyo, Naoki ^a   Fukai, Nozomi ^a   Ozawa, Naoko ^a   Doi, Masaru ^a   Yoshimoto, Takanobu ^a   Arii, Sigeki ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Glucose responsive insulinoma; Octreotide; Postprandial hypoglycemia

Indexed keywords

CHROMOGRANIN A; GLUCOSE; INSULIN; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIET RESTRICTION; DRUG EFFICACY; EATING; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN RESPONSE; INSULINOMA; INTRAVENOUS GLUCOSE TOLERANCE TEST; LAPAROTOMY; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL TUMOR; PANCREAS SCINTISCANNING; PHYSICAL ACTIVITY; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; INSULIN; INSULINOMA; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS;

EID: 33646784710     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1523     Document Type: Article

References (29)

1. Service FJ. Hypoglycemic disorders. N Engl J Med 332: 1144-1152, 1995.
2. Marks V. Recognition and differential diagnosis of spontaneous hypoglycemia. Clin Endocrinol 37: 309-316, 1992.
3. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719, 1991.
4. Doherty GM, Doppman JL, Shawker TH, et al. Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 110: 989-997, 1991.
5. Pasieka JL, McLeod MK, Thompson NW, Burney RE. Surgical approach to insulinoma; assessing the need for preoperative localization. Arch Surg 127: 442-447, 1992.
6. Grama D, Eriksson B, Martensson H, et al. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 16: 632-639, 1992.
7. Menegaux F, Schmitt G, Mercadier M, Chigot J-P. Pancreatic insulinomas. Am J Surg 165: 243-248, 1992.
8. Doi R, Komoto I, Nakamura Y, et al. Pancreatic endocrine tumor in Japan. Pancreas 28: 247-252, 2004.
9. Mittendorf EA, Liu YC, McHenry CR. Giant insulinoma: case report and review of the literature. J Clin Endocrinol Metab 90: 575-580, 2005.
10. Laroche GP, Eerris DO, Priestley JT, Sholz DA, Dockerty MB. Hyperinsulinism. Surgical results and management of occult functioning islet cell tumor: review of 154 cases. Arch Surg 96: 763-772, 1968.
11. Stefanini P, Carboni M, Patrassi N, Basoli A. Beta-islet cell tumors of the pancreas: results of a study on 1067 cases. Surgery 75: 597-609, 1974.
12. Service FJ, Dale AJD, Elveback LR, Jiang NS. Insulinoma: Clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51: 417-429, 1976.
13. Fajans SS, Floyd JC Jr. Fasting hypoglycemia in adults. N Engl J Med 294: 766-772, 1976.
14. Merimee TJ, Tyson JE. Hypoglycemia in man: Pathologic and physiologic variants. Diabetes 26: 161-165, 1977.
15. Frerichs H, Creutzfeldt W. Hypoglycaemia: 1.Insulin secreting tumors. Clin Endocrinol and Metab 5: 747-767, 1976.
16. Floyd JC Jr, Fajans SS, Knopf RF, Conn JW. Plasnia insulin in organic hyperinsulinism: Comparative effects of tolbutamide, leucine and glucose. J Clin Endocrinol Metab 24: 747-760, 1964.
17. Marks V, Samols E. Glucagon test for insulinoma: A chemical study in 25 cases. J Clin Pathol 21: 346-352, 1968.
18. Kumar D, Mehtalia SD, Miller LV. Diagnostic use of glucagon-induced insulin response: Studies in patients with insulinoma or other hypoglycemic conditions. Ann Intern Med 80: 697-701, 1974.
19. Brunt LM, Veldhuis JD, Dilley WG, et al. Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with beta-cell neoplasms of the pancreas. J Clin Endocrinol Metab 62: 210-216, 1986.
20. Wiesli P, Spinas GA, Pfammatter T, Krahenbuhl L, Schmid C. Glucose-induced hypoglycaemia. Lancet 360: 1476, 2002.
21. Sjoberg RJ, Kidd GS. Case Report: A glucose responsive insulinoma - Implication for the diagnosis of insulin secreting tumors. Am J Med Sci 304: 164-167, 1992.
22. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 334: 246-254, 1996.
23. Reubi JC, Kvols L, Krenning E, Lamberts SW. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 39 suppl2: 78-81, 1990.
24. Schaer JC, Waser B, Mengod G, Reubi JC. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. Int J Cancer 70: 530-537, 1997.
25. King CM, Reznek RH, Bomanji J, et al. Imaging neuroendocrine tumours with radiolabeled somatostatin analogues and X-ray computed tomography: a comparative study. Clin Radiol 48: 386-391, 1993.
26. 111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49: 1583-1591, 1991.
27. Lamberts SWJ, Hofland LJ, von Koetsveld PM, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab 71: 566-574, 1990.
28. Kubota A, Yamada Y, Kagimoto S, et al. identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93: 1321-1325, 1994.
29. Papotti M, Bongiovanni M, Volante M, et al. Expression of somatostatin receptor types 1-5 in 81cases of gastrointestinal and pancreatic endocrine tumors. Virchows Arch 440: 461-475, 2002.